Tiragolumab and Atezolizumab for the Treatment of Relapsed or Refractory SMARCB1 or SMARCA4 Deficient Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Centre Leon Berard
M.D. Anderson Cancer Center
University of Iowa
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Eli Lilly and Company
iOmx Therapeutics AG
Hoffmann-La Roche
Massachusetts General Hospital
Eli Lilly and Company
Sotio Biotech Inc.
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Northwestern University
Sarcoma Oncology Research Center, LLC
Bambino Gesù Hospital and Research Institute
Cybrexa Therapeutics
Case Comprehensive Cancer Center